QUICK ANSWER  Biogenique Collagen powder provides 7.8 g of hydrolyzed collagen from fish bone per adult serving. The reviewed Canadian label's recommended use is narrow: it is a source of the essential amino acid lysine to help in collagen formation. That is not a licensed promise to erase wrinkles, grow hair, strengthen nails, rebuild cartilage or treat osteoarthritis. Human research is encouraging for some joint outcomes and disputed for skin outcomes, but studies of other collagen peptides and formulations do not automatically prove results for this powder.

First, identify the exact Collagen product

Biogenique currently uses overlapping collagen names. This article is about the 234 g powder labelled Collagen, with 7.8 g of hydrolyzed fish-bone collagen per scoop and NPN 80071722. A separate product page sells Marine Collagen capsules containing 500 mg of hydrolyzed fish collagen per capsule under NPN 80132951. Those serving sizes, dosage forms and NPNs are not interchangeable.

That distinction matters for both readers and search engines. Calling the powder only 'Marine Collagen' can send visitors to the wrong product and make two pages compete for the same intent. Throughout this guide, 'the product' means the 7.8 g powder unless a study or monograph is being discussed more generally.

What is hydrolyzed fish collagen?

Collagen is a structural protein found in connective tissues. Hydrolysis uses controlled processing to break the larger protein into smaller peptides that disperse more easily in water. Health Canada's hydrolyzed collagen monograph describes this material as soluble in cold water and lists fish bone and fish skin among permitted sources. 'Hydrolyzed' describes the form; it does not by itself prove better clinical absorption, superior results or a specific molecular-weight profile for a finished product.

After ingestion, digestive enzymes further process dietary proteins and peptides. Amino acids and some small peptides can be absorbed and used throughout the body. The body does not simply route an intact scoop to the face or knee. That is why a plausible mechanism is not the same as a demonstrated outcome, and why product-specific dose, peptide composition and trial design still matter.

What exactly is in the Biogenique powder?

• Medicinal ingredient: hydrolyzed collagen from fish bone, 7.8 g per serving.

• Reviewed adult dose: one scoop, equal to 7.8 g, once daily.

• Container size: 234 g, equal to 30 labelled servings by arithmetic.

• Reviewed recommended use: source of the essential amino acid lysine to help in collagen formation.

• Product identifier: NPN 80071722.

• The reviewed artwork identifies the fish source and carries the marketing term 'pharmaceutical grade.'

The formula is simple, but simple does not mean every possible benefit is established. The label does not state a peptide trademark, peptide-size distribution, amino-acid assay, finished-product collagen assay or comparative bioavailability result. Those missing details limit claims about potency, absorption and equivalence to the preparations used in clinical trials.

What is this NPN label actually licensed to say?

The reviewed February 2025 label artwork states: 'Source of the essential amino acid lysine to help in collagen formation.' That is the product claim that can be repeated with the strongest confidence. It does not say the powder is licensed to improve skin hydration, reduce wrinkles, grow hair, strengthen nails, rebuild cartilage or treat joint disease.

The same artwork contains a duration statement telling users to take the product for a minimum of five months 'for joint pain,' even though joint pain does not appear in its recommended-use section. That is an internal label inconsistency, not permission to add a joint-pain claim to marketing. Confirm the current Health Canada licence and corrected artwork before describing NPN 80071722 as licensed for joint pain.

Health Canada's current ingredient monograph is broader than this reviewed label. It permits qualifying hydrolyzed-collagen applications to seek amino-acid and joint-pain uses within specified conditions. An ingredient monograph is a licensing pathway, however, not a claim sheet automatically inherited by every product that contains the ingredient.

How does 7.8 g compare with Health Canada's monograph ranges?

For adults, the current monograph lists 2.6 to 10 g per day when hydrolyzed collagen is used as a source of specified essential or non-essential amino acids, and 1.2 to 10 g per day for joint-pain uses. The product's 7.8 g daily serving falls inside both numerical ranges. Dose alignment is useful context, but it does not tell us which uses Health Canada authorized for this NPN; the current licence and label decide that.

The monograph also says products carrying a joint-pain use should be taken for at least five months to see beneficial effects. That is a minimum labelled duration, not a guarantee that everyone will improve and not a timeline for skin, hair or nail results. A consumer with persistent or worsening joint pain still needs appropriate assessment rather than simply extending supplement use.

Three evidence layers that should not be blended

What does the joint evidence show?

Recent syntheses suggest a real but modest signal. A 2024 trial-sequential meta-analysis included 35 randomized trials with 3,165 participants and reported small-to-moderate improvements in pain and function for collagen derivatives compared with controls. The certainty was rated moderate for pain and high for function in that analysis. A separate updated review of 11 randomized trials in knee osteoarthritis, published in 2025, also reported improvements in pain and function.

The practical limitation is product matching. Those reviews pooled different collagen categories, sources, doses, proprietary peptides, undenatured type II products and study populations. Their results cannot prove that this unbranded fish-bone powder has the same peptide profile or effect. The evidence supports careful language such as 'collagen derivatives have been studied for joint symptoms,' not a promise to regenerate cartilage, replace osteoarthritis treatment or work for every user.

PRACTICAL INTERPRETATION  At 7.8 g daily, the powder sits within Health Canada's ingredient-monograph range for joint-pain applications. But the reviewed NPN artwork licenses a lysine/collagen-formation use, not a matching joint-pain recommended use. Treat the research as educational context until the current licence wording is confirmed.

What does the skin evidence show?

The skin literature looks positive when all trials are pooled, but the quality signal is uncomfortable. A 2023 meta-analysis of 26 randomized trials involving 1,721 participants found improvements in hydration and elasticity, while also identifying biases and calling for larger trials. Products, sources, doses, durations and measurement methods varied, so the pooled average is not a product-specific guarantee.

A 2025 meta-analysis examined 23 randomized trials with 1,474 participants. Overall pooling again favoured collagen for hydration, elasticity and wrinkles. However, the effects disappeared in studies without pharmaceutical-company funding and in higher-quality studies. The authors concluded that current clinical evidence does not support collagen supplements to prevent or treat skin aging. That does not prove collagen can never affect skin; it means 'clinically proven anti-aging' is not a responsible summary of the evidence.

For this product, the safe editorial boundary is clear: explain that collagen has been researched for skin measures, then state that the evidence is contested and not specific to NPN 80071722. Do not promise wrinkle reduction, firmer skin, faster skin repair or a visible result by a certain week.

What about hair and nails?

Hair and nail claims are weaker. One often-cited nail study followed only 25 participants, used a specific branded peptide at 2.5 g daily, and had no placebo control. It reported faster nail growth and fewer broken nails, but an open-label study of one proprietary ingredient cannot establish the same outcome for this fish-bone powder. Evidence for hair growth is even less direct and commonly involves multi-ingredient formulas, making the active contribution of collagen impossible to isolate.

Accordingly, 'supports healthy hair and nails' should not be presented as the licensed benefit of this NPN unless current licence documentation shows that wording. A reader with new hair loss, nail changes or brittleness may need assessment for nutritional, endocrine, dermatologic or medication-related causes.

Is collagen a complete protein?

No. Collagen lacks the indispensable amino acid tryptophan and has a different essential-amino-acid profile from complete proteins such as dairy, egg, meat, fish or properly combined plant sources. The powder can contribute amino acids - including lysine, which anchors its reviewed licensed use - but it should not be marketed as a one-for-one replacement for a complete dietary protein or a balanced meal.

A 2019 protein-quality analysis found that moderate collagen-peptide intake can fit within an otherwise adequate mixed diet without compromising overall amino-acid balance. That conclusion depends on the rest of the diet supplying indispensable amino acids. It does not turn collagen into a complete protein or prove it is superior to complete protein for muscle protein synthesis.

Is fish collagen better than bovine collagen?

'Marine' or 'fish' identifies source, not clinical rank. Fish, bovine and porcine collagens can differ in raw material, processing and peptide distribution, but source alone does not prove one product absorbs better or works faster. The 2023 skin meta-analysis found no significant source-related difference for elasticity, and hydration results varied. A meaningful comparison would require matched finished-product testing or a direct human trial, not a generic statement about smaller peptides.

The source still matters for dietary preference and allergy. This product is explicitly derived from fish bone. Anyone with fish allergy should not assume that hydrolysis makes it suitable; check the current label and obtain individualized advice before use.

How to take this exact 7.8 g powder

The reviewed label directs adults to take one scoop, equal to 7.8 g, once daily. At that dose, a 234 g container supplies 30 servings. Health Canada's monograph describes hydrolyzed collagen as soluble in cold water, but the reviewed label does not prescribe a particular drink, meal, clock time or mixing temperature. Follow the current package directions and measure with the supplied scoop rather than estimating by eye.

Consistency matters more than inventing a precise morning or evening rule. More is not automatically better: the labelled 7.8 g serving is already within the monograph's 10 g daily maximum for the discussed uses. Do not double the scoop to chase faster cosmetic or joint results, and do not use a research dose from another formula as a replacement for this product's directions.

Safety, cautions and when to seek care

The reviewed label says to consult a health-care practitioner before use if pregnant or breastfeeding. It also directs people with liver or kidney disease, or those instructed to follow a low-protein diet, to consult before use. Mild gastrointestinal disturbances can occur. Keep the product out of reach of children, protect it from heat and moisture, and do not use it if the outer seal is missing or broken.

For joint pain, seek professional advice if symptoms worsen. Urgent assessment is appropriate after a major injury, for a hot or markedly swollen joint, fever, inability to bear weight, new weakness or numbness, or pain accompanied by other concerning symptoms. A supplement should not delay diagnosis or established care.

What the historical lot-specific COA adds

The reviewed certificate of analysis covers Biogenique Collagen lot 240538, manufactured in May 2024, approved October 28, 2024 and labelled to expire in April 2026. It reports a 7.80 g serving weight against a 7.8 g plus-or-minus 7.5% specification. The powder description, moisture, bulk density and tapped density were reported within the listed specifications.

For that lot, the COA reports total plate count of 80 CFU/g, yeast and mould of 100 CFU/g, and negative results for E. coli, Salmonella, S. aureus and P. aeruginosa. It also lists arsenic, cadmium, lead and mercury results below the stated daily-exposure limits. Those are useful physical, microbial and contaminant checks for lot 240538 only.

The document does not display a separate finished-product collagen identity or potency assay, peptide profile, molecular-weight distribution or bioavailability result. It therefore does not substantiate 'pharmaceutical grade,' better absorption, clinical potency or every-batch testing claims. Because the lot expired in April 2026 and the product page was out of stock when reviewed in August 2026, a current in-date lot and COA are needed before publishing present-tense batch-quality claims.

Frequently asked questions

How many servings are in the container?

The container holds 234 g and the reviewed adult serving is 7.8 g. Dividing 234 by 7.8 gives 30 servings. That calculation assumes one level supplied scoop accurately measures the labelled serving.

Is 7.8 g a clinically proven dose?

It is the licensed daily amount for this product and falls within Health Canada's ingredient-monograph ranges for specified amino-acid and joint-pain applications. 'Within a monograph range' is not the same as proving every outcome reported with other peptide preparations at similar gram doses.

How long does collagen take to work?

There is no universal timeline. Health Canada's monograph specifies at least five months when a qualifying product carries a joint-pain use. Skin trials often run for weeks or months, but their findings are contested and not product-specific. Do not promise visible skin, hair or nail results by a fixed date.

Can I use this powder instead of protein powder?

Not as a nutritional equivalent. Collagen is an incomplete protein because it lacks tryptophan and is not balanced like a complete protein source. It can complement an adequate diet, but it should not displace the complete protein needed to meet overall nutrition goals.

Does fish collagen absorb better?

The reviewed product files contain no direct human comparison showing that this fish-bone powder absorbs better than a matched bovine or porcine product. Hydrolysis supports dispersibility, but source labels and generic peptide-size claims do not establish comparative clinical absorption.

Is 'pharmaceutical grade' verified?

The phrase appears on the reviewed package artwork, but the reviewed files do not identify a recognized pharmacopoeial grade, finished-product collagen assay or comparative standard that would define it. Treat the term as a substantiation issue, not as evidence of medical-grade performance.

The bottom line

Biogenique Collagen powder has a clear formula: 7.8 g of hydrolyzed fish-bone collagen per adult scoop, once daily, in a 234 g container. The reviewed label's defensible product benefit is equally clear: a source of the essential amino acid lysine to help in collagen formation. The dose falls within Health Canada's current hydrolyzed-collagen monograph ranges, but that does not automatically add every optional monograph use to NPN 80071722.

Research on collagen derivatives suggests possible benefits for some joint outcomes, while newer skin evidence is sharply limited by funding and study quality. Hair and nail evidence is not strong enough for confident product promises. Keep the article useful by distinguishing the powder from the 500 mg capsule product, using the exact label claim, explaining the evidence boundary and updating the label and COA before publication.

PUBLICATION GATE  Confirm the current Health Canada licence for NPN 80071722 and correct the mismatch between the label's lysine recommended use and its separate five-month joint-pain duration line. Name the SKU 'Collagen Powder 7.8 g' so it cannot be confused with Marine Collagen 500 mg capsules (NPN 80132951). Remove or qualify skin, hair, nail, anti-aging, cartilage-rebuilding, better-absorption, pharmaceutical-grade, purity, potency and every-batch claims. Replace expired lot 240538 documentation with a current in-date label and COA, and verify availability before sending traffic to the product page.

Product link

View Biogenique Collagen Powder

Sources

1. Health Canada. Hydrolyzed Collagen monograph. March 28, 2024.

2. Health Canada. Licensed Natural Health Products Database.

3. Biogenique. Collagen Powder product page, NPN 80071722.

4. Biogenique. Reviewed Collagen label artwork for NPN 80071722, lot 240538, expiry April 2026.

5. Biogenique / Medicap Laboratories. Certificate of Analysis: Collagen lot 240538, approved October 28, 2024.

6. Liang CW, Cheng HY, Lee YH, et al. Efficacy and safety of collagen derivatives for osteoarthritis: a trial sequential meta-analysis. Osteoarthritis Cartilage. 2024;32(5):574-584.

7. Simental-Mendia M, Ortega-Mata D, Acosta-Olivo CA, et al. Effect of collagen supplementation on knee osteoarthritis: an updated systematic review and meta-analysis of randomised controlled trials. Clin Exp Rheumatol. 2025;43(1):126-134.

8. Pu SY, Huang YL, Pu CM, et al. Effects of Oral Collagen for Skin Anti-Aging: A Systematic Review and Meta-Analysis. Nutrients. 2023;15(9):2080.

9. Myung SK, Park Y. Effects of Collagen Supplements on Skin Aging: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Am J Med. 2025;138(9):1264-1277.

10. Paul C, Leser S, Oesser S. Significant Amounts of Functional Collagen Peptides Can Be Incorporated in the Diet While Maintaining Indispensable Amino Acid Balance. Nutrients. 2019;11(5):1079.

11. Hexsel D, Zague V, Schunck M, et al. Oral supplementation with specific bioactive collagen peptides improves nail growth and reduces symptoms of brittle nails. J Cosmet Dermatol. 2017;16(4):520-526.

Educational information only; not medical advice. Natural health product claims, directions and risk statements are product- and licence-specific. Always read the current label.